OWL Technology - What is metabolomics
A combination of data-rich analytical chemistry and chemometrics for profiling metabolism in complex systems.
Metabolomics involves the extraction and measurement of multiple small molecules from tissues or biofluids to produce metabolic profiles. Comparison of such profiles from different phenotypes can be used to identify specific metabolic changes leading to the understanding of physiology, toxicology and disease progression. The less complex, more quantitative, biochemically specific metabolomics approach is proving advantageous over rival technologies such as genomics, transcriptomics and proteomics and is growing rapidly in an increasing range of fields such as disease diagnosis, drug development, plant science, and nutrition.
OWL has established a state-of-the-art mass spectrometry based metabolomics platform ideally suited for the study of liver disease biomarkers, currently the company’s main research front. In addition to this ongoing research effort, OWL conducts metabolomics studies for other pharmaceutical and biotechnology companies in key areas such as biomarker discovery, clinical studies, diagnostics and toxicology.